Hypogammaglobulinaemia following rituximab therapy in childhood nephrotic syndrome
- 9 January 2022
- journal article
- editorial
- Published by Springer Nature in Pediatric Nephrology
- Vol. 37 (5) , 927-931
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trialThe Lancet, 2014
- Fulminant viral myocarditis after rituximab therapy in pediatric nephrotic syndromePediatric Nephrology, 2013
- Fatal pulmonary fibrosis after rituximab administrationPediatric Nephrology, 2009
- The emergence of progressive multifocal leukoencephalopathy (PML) in rheumatic diseasesJournal of Autoimmunity, 2008
- Assessment and clinical interpretation of reduced IgG valuesAnnals of Allergy, Asthma & Immunology, 2007
- Reactivation of hepatitis B virus with rituximabExpert Opinion on Drug Safety, 2005
- Serum levels of immunoglobulins and IgG subclasses in steroid sensitive nephrotic syndromePediatric Nephrology, 2002
- Racial differences in serum immunoglobulin levels: Relationship to cigarette smoking, t‐cell subsets, and soluble interleukin‐2 receptorsJournal of Clinical Laboratory Analysis, 1995
- Corticosteroid effect on immunoglobulinsJournal of Allergy and Clinical Immunology, 1978
- Serum Immunoglobulins in the Nephrotic SyndromeNew England Journal of Medicine, 1975